Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse

NCT03558529

Conditions: Disease Attributes, Mental Disorders, Pathologic Processes, +8 more
Locations: Not specified

View Trial Details

Completed

Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma

NCT00729053

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations: Georgetown University, Lombardi Cancer Center Washington D.C., District of Columbia, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

NCT02210858

Conditions: Accelerated Phase of Disease, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +21 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

University of Rochester Rochester, New York, United States

View Trial Details

Completed

Artemisinin-resistant Malaria in Cambodia

NCT01736319

Conditions: Disease Attributes, Infections, Malaria, +9 more
Locations: National Center for Parasitology, Entomology, and Malaria Controk, Ministry of H Phnom Penh, Cambodia

View Trial Details

Completed

VA Augmentation and Switching Treatments for Improving Depression Outcomes

NCT01421342

Conditions: Behavior, Behavioral Symptoms, Depression, +11 more
Locations: Tuscaloosa VA Medical Center, Tuscaloosa, AL Tuscaloosa, Alabama, United States

Phoenix VA Health Care System, Phoenix, AZ Phoenix, Arizona, United States

Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States

VA Loma Linda Healthcare System, Loma Linda, CA Loma Linda, California, United States

View all 35 locations

View Trial Details

Completed

Phase 1 and 2 Study of PX-866 and Cetuximab

NCT01252628

Conditions: Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +30 more
Locations: Birmingham Hematology and Oncology Assocs. Birmingham, Alabama, United States

University of Alabama Birmingham Birmingham, Alabama, United States

Southwest Cancer Care Escondido, California, United States

Monterey Bay Oncology Monterey, California, United States

View all 40 locations

View Trial Details

Completed

Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria

NCT02216123

Conditions: Disease Attributes, Hemolysis, Infections, +9 more
Locations: GSK Investigational Site Manaus, Amazonas, Brazil

GSK Investigational Site Cali, Colombia

GSK Investigational Site Montería, Colombia

GSK Investigational Site Gonder, Ethiopia

View Trial Details

Completed

Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT01191190

Conditions: CLL, Chronic Disease, Disease Attributes, +15 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

University of California San Diego, Moores Cancer Center La Jolla, California, United States

View Trial Details

Completed

The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)

NCT02323854

Conditions: Disease Attributes, Lung Cancer, Lung Diseases, +9 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Weill Cornell Medical College New York, United States

Rhode Island Hospital Providence, Rhode Island, United States

University Hospital Frankfurt Frankfurt, Germany

View Trial Details

Completed

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

NCT01458717

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +10 more
Locations: Center for Liver Cancer, National Cancer Center Goyang-si, Gyeonggi-do, South Korea

Seoul National University Bundang Hospital Seongnam, South Korea

Seoul National University Hospital Seoul, South Korea

Samsung Medical Center Seoul, South Korea

View Trial Details

Recurrence

Recurrence trial results

Related conditions